Seres' news, events and other information can be found throughout the pages below. Investor Relations. Stock Information · Stock Quote & Chart · Historical. View the MCRB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Seres Therapeutics Inc. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio. Seres Therapeutics Inc. engages in the development of biological drugs through microbiome therapeutics platform. Seres Therapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A.
In the same quarter last year, Seres Therapeutics's earnings per share (EPS) was -$ Seres Therapeutics is expected to release next earnings on 08/12/ Discover real-time Seres Therapeutics, Inc. Common Stock (MCRB) stock prices, quotes, historical data, news, and Insights for informed trading and. The Investor Relations website contains information about Seres Therapeutics's business for stockholders, potential investors, and financial analysts. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Get the latest Seres Therapeutics Inc. (MCRB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The current price of MCRB is USD — it has increased by % in the past 24 hours. Watch Seres Therapeutics, Inc. stock price performance more closely on. Track Seres Therapeutics Inc (MCRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. MCRB is not. In the same quarter last year, Seres Therapeutics's earnings per share (EPS) was -$ Seres Therapeutics is expected to release next earnings on 08/12/ The 16 analysts offering price forecasts for Seres Therapeutics have a median target of , with a high estimate of and a low estimate of Latest Seres Therapeutics Inc (MCRB:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Track Seres Therapeutics Inc (MCRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get. Seres Therapeutics stock tanks 78% after 'unexpected' negative midstage trial results. Seres Therapeutics Inc. shares cratered 78% in pre-market trade Friday. Even after rising 29% this past week, Seres Therapeutics (NASDAQ:MCRB) shareholders are still down 84% over the past three years. Seres Therapeutics, Inc. . Research Seres Therapeutics' (Nasdaq:MCRB) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. What was Seres Therapeutics's price range in the past 12 months? Seres Therapeutics lowest stock price was $ and its highest was $ in the past 12 months. Seres Therapeutics, Inc. (US:MCRB) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Seres Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Stock analysis for Seres Therapeutics Inc (MCRB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company.
Seres Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MCRB. The last closing price for Seres Therapeutics was. Seres Therapeutics Inc MCRB:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/05/23 · 52 Week Low Akebia Therapeutics Inc. $ AKBA % ; Amarin Corporation plc. $ AMRN % ; TG Therapeutics Inc common stock. $ TGTX %. Seres Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MCRB. The last closing price for Seres Therapeutics was. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for.
Seres' lead product candidate, SER, is designed to reduce further recurrences of Clostridioides difficle infection (CDI). Headquarters: Sidney. MCRB Related stocks ; Seres Therapeutics Inc ; AMGN, , +% ; Amgen Inc ; REGN, 1,, +%. View Seres Therapeutics (MCRB) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with. View the latest MCRB share price or buy & sell Seres Therapeutics stock on NASDAQ using Lightyear. Seres Therapeutics Inc is a microbiome therapeutics. Seres Therapeutics (MCRB) · After Hours PM ET 08/23/ $ %. Previous Close · $ · ; % · Volume: Mil · Volume % Chg: 47% · Get a. Find the latest institutional holdings data for Seres Therapeutics, Inc. Common Stock (MCRB) including shareholders, ownership summaries. Seres Therapeutics Inc ; Oct, Initiated, Oppenheimer, Outperform, $19 ; Aug, Reiterated, H.C. Wainwright, Buy, $15 → $